RxDoctor Payments DataLook up a doctor →

Val Warner, PA

Medical · Layton, UTNPI 1366819575

Payments from drug & device makers

$50,543in general payments, 2019–2025

Across 907 payments — averaging $55.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alnylam Pharmaceuticals Inc.$18K
  • Pfizer$12K
  • Biohaven Pharmaceuticals, Inc.$8K
  • AbbVie$4K
  • Biohaven Pharmaceutical Holding Company Ltd.$1K
  • Novo Nordisk$876
  • plus $7K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alnylam Pharmaceuticals Inc.47$17,656
Pfizer46$11,782
Biohaven Pharmaceuticals, Inc.27$8,469
AbbVie289$4,114
Biohaven Pharmaceutical Holding Company Ltd.11$1,094
Novo Nordisk75$876
Amgen(2 entities)48$680
Lilly USA, LLC45$599
Novartis30$529
Axsome Therapeutics, Inc.26$421
Astellas Pharma US Inc23$390
Nestle Healthcare Nutrition Inc.15$255
GSK16$244
Lundbeck LLC14$241
Boehringer Ingelheim12$225
Otsuka America Pharmaceutical, Inc.12$204
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$199
AstraZeneca13$190
Sumitomo Pharma America, Inc.10$184
Takeda Pharmaceuticals U.S.A., Inc.9$171
Sanofi-aventis U.S. LLC11$157
Daiichi Sankyo Inc.9$150
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$145
Biogen6$103
Antares Pharma, Inc.5$95
Johnson & Johnson5$91
Avanir Pharmaceuticals, Inc.6$85
Idorsia Pharmaceuticals US Inc5$77
Dexcom, Inc.5$73
Aimmune Therapeutics, Inc.4$68
Amarin Pharma, Inc.4$62
Alkermes, Inc.4$58
Phathom Pharmaceuticals, Inc.3$49
Corium, LLC3$46
Kowa Pharmaceuticals America, Inc.2$46
E.r. Squibb & Sons, L.L.C.3$45
Harmony Biosciences LLC3$45
Bausch Health US, LLC3$42
Neurocrine Biosciences, Inc.2$40
Jazz Pharmaceuticals Inc.3$40
Halozyme Inc2$39
Sunovion Pharmaceuticals Inc.3$39
Bayer2$37
Corcept Therapeutics2$33
Ardelyx, Inc.2$32
Shield Therapeutics Inc1$29
Exact Sciences2$29
Lucid Diagnostics Inc.2$29
ANI Pharmaceuticals, Inc.1$26
Bard Peripheral Vascular, Inc.1$21
Lifescan, Inc.1$21
Abbott1$20
Grifols USA, LLC1$19
Pharmacosmos Therapeutics Inc.1$18
Inspire Medical Systems, Inc.1$17
Teva Pharmaceuticals USA, Inc.1$16
Genentech USA, Inc.1$14
Redhill Biopharma Inc.1$14
Boston Scientific1$13
Merck1$12

How this compares

$50,543 in reported general payments places this provider in the 95th percentile of 263 medical providers in Utah.

See all medical providers in Utah →

Medicare billing

Part B allowed, 2024
$88,131
Medicare patients
236
Services billed
9,531

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Layton

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →